Biofrontera (BFRI) Shares Outstanding (Weighted Average) (2020 - 2025)

Biofrontera's Shares Outstanding (Weighted Average) history runs 6 years deep, the most recent figure standing at $10.2 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) rose 84.4% year-over-year to $10.2 million; the TTM figure through Dec 2025 stood at $10.2 million (up 84.4% YoY), while the FY2025 annual figure was $10.2 million, up 84.4% from the prior year.
• Shares Outstanding (Weighted Average) was $10.2 million for Q4 2025 at Biofrontera, up from $9.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $17.1 million in Q1 2022 to a low of $898444.0 in Q2 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $5.8 million across 5 years, with a median of $5.6 million in 2024.
• The sharpest annual moves came in 2021 and 2023: Shares Outstanding (Weighted Average) jumped 799900.0% in 2021, then tumbled 92.2% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $8.8 million in 2021, then sank by 88.0% to $1.1 million in 2022, then soared by 46.29% to $1.5 million in 2023, then jumped by 256.74% to $5.5 million in 2024, then jumped by 84.4% to $10.2 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $10.2 million (Q4 2025), $9.7 million (Q3 2025), and $9.4 million (Q2 2025), per Business Quant data.